Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Date:8/5/2009

the following: There can be no assurance that the Company will complete cost-effective clinical trials or meet the projected development timelines for the drug candidates in its pipeline, including Zerenex and KRX-0401; that the Company will be able to raise additional capital in the future in order to fund its operations; or that the Company's stock will not be affected by other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available athttp://www.keryx.com. The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.

    KERYX CONTACT:
    Lauren Fischer
    Director - Investor Relations
    Keryx Biopharmaceuticals, Inc.
    Tel: 212.531.5965
    E-mail: lfischer@keryx.com

                              Keryx Biopharmaceuticals, Inc.
                           Selected Consolidated Financial Data
                    (In Thousands, Except Share and Per Share Amounts)

    Statements of Operations Information:

                                   Three Months Ended     Six Months Ended
                                        June 30,               June 30,
                                      (unaudited)            (unaudited)
                                    2009       2008        2009       2008


    REVENUE:
    License revenue            $  18,289     $  327   $  21,616     $  526
    Service revenue                   --         62           3         62
    Other reven
'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 17, 2014 Using microscopic polymer light resonators ... researchers at MIT,s Quantum Photonics Laboratory have developed ... the parts-per-billion range. Optical sensors are ideal for ... signal-to-noise ratio, compact, lightweight nature, and immunity to ... had been developed before, the MIT team conceived ...
(Date:7/10/2014)... observed the fractional quantum Hall effect in bilayer graphene ... be tuned by an electric field. , The ... confined to thin sheets are exposed to large magnetic ... thousands of individual electrons behave as a single system. ... well established, many details of this collective behavior remain ...
(Date:7/10/2014)... have shelled out for crude 3-D glasses, polarized ... experience. These basic devices, used to trick the ... soon be rendered obsolete with the introduction of ... researchers. , TAU doctoral students Yuval Yifat, Michal ... holography based on nanoantennas that could be used ...
(Date:1/15/2014)... an approach akin to assembling a club sandwich ... Technology (NIST) researchers have succeeded in crafting a ... flammability of foam commonly used in upholstered furniture ... the nanotube-coated polyurethane foam was reduced 35 percent ...
Breaking Biology Technology:Swell new sensors 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Layered security: Carbon nanotubes promise improved flame-resistant coating 2
... 28 Cylene Pharmaceuticals has appointed,Dr. Kenna Anderes ... 17 years,of life sciences research experience with a ... President of Cancer Biology. With Cylene,s,most advanced compound, ... will be leading Cylene,s biology and pre-clinical research,teams ...
... - Oncothyreon Inc. (the,"Company") (Nasdaq: ONTY ) ... innovative therapeutic products for the treatment of,cancer, today ... plans,and corporate objectives for 2008. Oncothyreon is developing ... the potential to,improve the lives and outcomes of ...
... MNKD ), focused on discovering, developing and,commercializing treatments ... at the Wachovia Healthcare Conference on January 30, 2008 ... MA., Interested parties can access a link to ... Relations section of the Company,s website at, http://www.mannkindcorp.com . ...
Cached Biology Technology:Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology 2Oncothyreon highlights corporate and clinical objectives for 2008 2Oncothyreon highlights corporate and clinical objectives for 2008 3Oncothyreon highlights corporate and clinical objectives for 2008 4Oncothyreon highlights corporate and clinical objectives for 2008 5
(Date:7/10/2014)... 2014 Amyloid diseases, such as Alzheimer,s disease, ... all share the common trait that proteins aggregate ... in vitro studies have found that neither the ... very toxic. New evidence using two-dimensional infrared (2D ... the amylin aggregation pathway that may explain toxicity, ...
(Date:7/10/2014)... (July 10, 2014) New research from The University ... that It,s Your GameKeep it Real (IYG), a health ... healthy dating relationships, can significantly reduce dating violence behaviors ... Disease Control and Prevention, 10 percent of high school ... studies suggest that more than 20 percent are victims ...
(Date:7/10/2014)... NOAA and its research partners predict that western Lake ... toxic blue-green algae, during the 2014 bloom season in ... be smaller than last year,s intense bloom, and considerably ... will vary across the lake,s western basin and are ... how far it spreads. , Harmful algal blooms ...
Breaking Biology News(10 mins):New technology reveals insights into mechanisms underlying amyloid diseases 2It's Your Game ... Keep It Real reduces dating violence among minority youth 2NOAA, partners predict significant harmful algal bloom in western Lake Erie this summer 2NOAA, partners predict significant harmful algal bloom in western Lake Erie this summer 3
... MABrown seems to be the color of choice when it comes to ... while its counterpart, white fat stores it. The danger in white fat ... poses, seems especially linked to visceral fat. Visceral fat is the build-up ... in the battle against obesity, brown fat appears to be our friend ...
... This release is available in German . ... plant species develop special strategies. These differ in part considerably ... Ingolf Khn and Dr. Sonja Knapp of the Helmholtz Centre ... published in the current issue of the scientific journal ...
... NOAA scientists and their colleagues have discovered a biological ... mammals that shows when they have been repeatedly exposed ... toxic at high levels. While little is ... marine animals or humans, high-level exposure through eating contaminated ...
Cached Biology News:A new candidate pathway for treating visceral obesity 2Different recipes for success in the world of plants 2Different recipes for success in the world of plants 3NOAA discovers way to detect low-level exposure to seafood toxin in marine animals 2
Monoclonal antibodies conjugated with rhodamine...
... p- methoxyhydrocinnamamido)-3′-deoxy-N,N-dimethyladenosine, 2HCl White ... Protein synthesis inhibitor. Inhibits translation by ... chains. Induces DNA fragmentation in thymocytes ... Purity: ≥98% by TLC. ...
Mouse monoclonal antibody to PPP2R2C - protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform...
...
Biology Products: